Interferon-free BMS combo cures 90% of genotype 1 hepatitis C
Merck combination suppresses HCV in mono-infected and co-infected patients
Early treatment reduces viral reservoirs but does not prevent rebound
Dapivirine vaginal ring safe and effective in tissue study, but maraviroc component doesn't work
Early antiretroviral therapy may limit gut damage and immune activation
Women with circumcised partners less likely to have HIV, no less likely to use condoms
Monitoring may be an option for people living with HIV diagnosed with high-grade pre-cancerous anal lesions
Very different levels of PrEP uptake and adherence in three US cities, demonstration project finds
Heart attack link to abacavir persists in D:A:D study
Daclatasvir plus simeprevir are effective against hepatitis C genotype 1b
Efavirenz-based ART matches lopinavir/ritonavir for perinatal HIV treatment
Massive scale-up of HIV testing, plus HIV treatment on diagnosis, needed to curtail UK gay epidemic
Only having sex with same-status partners is an HIV prevention strategy for 40% of gay men
Sexually transmitted infections greatly increase the risk of HIV infection in pregnancy
New NNRTI doravirine matches efavirenz for first-line HIV treatment
Lopinavir/ritonavir or 3TC PrEP equally protective against infant HIV infection during breastfeeding
Heart attack risk in people with HIV may be falling – but not in women
Nipping HIV in the bud: could we use genotyping to interrupt transmission?
